Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$7,666,715
+$1,174,856 QoQ
Shares Held
30,467
+2.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#1,051
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roundview Capital LLC holds $44,317,424 across 9 Drug Manufacturers - General names. ABBV ranks #3 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
72,050 | $18,298,538 | |
| 2 | LLY |
ELI LILLY & Co
|
8,070 | $9,679,400 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
30,467 | $7,666,715 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,411 | $5,449,813 | |
| 5 | NVO |
Novo Nordisk A S
|
32,028 | $1,535,422 | |
| 6 | PFE |
Pfizer Inc
|
23,438 | $564,387 | |
| 7 | NVS |
Novartis AG
|
2,707 | $424,241 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,618 | $381,329 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,666,715 | 30,467 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $6,491,859 | 29,849 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $6,737,484 | 29,487 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $6,807,507 | 29,401 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,429,385 | 29,250 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $6,059,527 | 28,921 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $5,103,544 | 28,720 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,520,553 | 27,955 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,779,919 | 27,868 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,996,824 | 27,440 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $4,140,488 | 26,718 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,810,464 | 32,272 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,355,551 | 32,328 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,136,335 | 32,229 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $5,155,035 | 31,898 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,221,709 | 31,456 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,741,067 | 30,955 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,982,775 | 30,737 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $4,792,347 | 35,394 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,847,183 | 35,665 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,838,883 | 34,081 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,293,892 | 30,437 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,883,651 | 36,245 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,722,750 | 42,502 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $5,233,190 | 53,302 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,464,435 | 45,471 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||